Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700033689

Trial Profile

Clinical Trials Insight: 700033689

Phase of Trial: Phase I

Latest Information Update: 19 May 2008

At a glance

  • Drugs Adipiplon (Primary)
  • Indications Anxiety disorders
  • Focus Pharmacodynamics
  • Sponsors Neurogen Corporation
  • Most Recent Events

    • 19 May 2008 New trial record.
    • 08 May 2008 Results are expected by the end of 2008, according to information from a Neurogen Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top